Bolt Biotherapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
QUINN WILLIAM P. officer: Chief Financial Officer
Common Stock 7,500 $0.95 $7,125
Purchase
QUINN WILLIAM P. officer: Chief Financial Officer
Common Stock 2,500 $0.78 $1,955
Sale
ENGLEMAN EDGAR director
Common Stock 108,145 $0.86 $92,788
Sale
ENGLEMAN EDGAR director
Common Stock 14,934 $0.86 $12,813
Sale
ENGLEMAN EDGAR director
Common Stock 22,674 $0.91 $20,543
Sale
ENGLEMAN EDGAR director
Common Stock 3,131 $0.91 $2,837
Sale
VIVO CAPITAL VIII, LLC 10 percent owner
Common Stock 1,707 $0.9 $1,536
Sale
VIVO CAPITAL VIII, LLC 10 percent owner
Common Stock 236 $0.9 $212
Sale
VIVO CAPITAL VIII, LLC 10 percent owner
Common Stock 1,457 $0.9 $1,311
Sale
ENGLEMAN EDGAR director
Common Stock 1,707 $0.9 $1,538
Sale
ENGLEMAN EDGAR director
Common Stock 236 $0.9 $213
Sale
ENGLEMAN EDGAR director
Common Stock 27,465 $0.92 $25,268
Sale
ENGLEMAN EDGAR director
Common Stock 3,792 $0.92 $3,489
Sale
VIVO CAPITAL VIII, LLC 10 percent owner
Common Stock 27,465 $0.92 $25,268
Sale
VIVO CAPITAL VIII, LLC 10 percent owner
Common Stock 3,792 $0.92 $3,489
Sale
VIVO CAPITAL VIII, LLC 10 percent owner
Common Stock 23,443 $0.92 $21,568
Sale
ENGLEMAN EDGAR director
Common Stock 8,211 $0.93 $7,636
Sale
ENGLEMAN EDGAR director
Common Stock 1,134 $0.93 $1,055
Sale
VIVO CAPITAL VIII, LLC 10 percent owner
Comon Stock 8,211 $0.93 $7,636
Sale
VIVO CAPITAL VIII, LLC 10 percent owner
Common Stock 1,134 $0.93 $1,055
Sale
VIVO CAPITAL VIII, LLC 10 percent owner
Common Stock 7,009 $0.93 $6,518
Sale
ENGLEMAN EDGAR director
Common Stock 7,531 $0.96 $7,230
Sale
ENGLEMAN EDGAR director
Common Stock 1,040 $0.96 $998
Sale
VIVO CAPITAL VIII, LLC 10 percent owner
Common Stock 7,531 $0.96 $7,230
Sale
VIVO CAPITAL VIII, LLC 10 percent owner
Common Stock 1,040 $0.96 $998
Sale
VIVO CAPITAL VIII, LLC 10 percent owner
Common Stock 6,429 $0.96 $6,172
Sale
NOVO HOLDINGS A/S 10 percent owner
COMMON STOCK 800,000 $2 $1,600,000
Option
PEREZ EDITH A. officer: Chief Medical Officer
Stock Option (Right to Buy) 35,714 $2.8 $99,999
Option
PEREZ EDITH A. officer: Chief Medical Officer
Common Stock 35,714 $2.8 $99,999
Purchase
QUINN WILLIAM P. officer: Chief Financial Officer
Common Stock 5,000 $4.72 $23,575
Purchase
QUINN WILLIAM P. officer: Chief Financial Officer
Common Stock 35 $4.64 $162
Purchase
QUINN WILLIAM P. officer: Chief Financial Officer
Common Stock 1,221 $16.65 $20,330
Purchase
SOFINNOVA VENTURE PARTNERS X, L.P. 10 percent owner
Common Stock 450,000 $20 $9,000,000
Purchase
VIVO CAPITAL VIII, LLC 10 percent owner
Common Stock 350,000 $20 $7,000,000
Sale
VIVO CAPITAL VIII, LLC 10 percent owner
Common Stock 226 $20 $4,520
Purchase
ENGLEMAN EDGAR director, 10 percent owner
Common Stock 200,000 $20 $4,000,000
Sale
ENGLEMAN EDGAR director, 10 percent owner
Common Stock 164 $20 $3,280
Purchase
NOVO HOLDINGS A/S 10 percent owner
COMMON STOCK 400,000 $20 $8,000,000
Sale
SHAH MAHENDRA director
Common Stock 62 $20 $1,240
Purchase
QUINN WILLIAM P. officer: Chief Financial Officer
Common Stock 1,200 $20 $24,000
Purchase
SCHATZMAN RANDALL C director, officer: Chief Execut..
Common Stock 1,500 $20 $30,000
Purchase
KHANNA ASHISH SIRI RAM director
Common Stock 2,200 $20 $44,000
Purchase
LAPORTE KATHLEEN director
Common Stock 1,200 $20 $24,000
Purchase
HEALY JAMES director
Common Stock 450,000 $20 $9,000,000
Sale
VIVO CAPITAL VIII, LLC 10 percent owner
Common Stock 226 $20 $4,520
Sale
ENGLEMAN EDGAR director, 10 percent owner
Common Stock 164 $20 $3,280

Showing 1 to 46 of 46 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.